Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,397 | -45,343 | -33,777 | -16,230 | -23,763 |
| Depreciation Amortization | -430 | 2,228 | 1,670 | 1,722 | 1,789 |
| Other Working Capital | 15,012 | -833 | -2,588 | -2,261 | 206 |
| Other Operating Activity | 2,594 | 2,062 | 1,620 | 1,468 | 1,755 |
| Operating Cash Flow | $-33,221 | $-41,886 | $-33,075 | $-15,301 | $-20,013 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -15,927 | 48,707 | -91,424 | 7,084 | 4,953 |
| PPE Investments | -4,200 | -1,462 | -142 | -184 | -28 |
| Investing Cash Flow | $-20,127 | $47,245 | $-91,566 | $6,900 | $4,925 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -394 | -66 | N/A | -9,083 | -8,000 |
| Common Stock Issued | 66,624 | 5,517 | 110,025 | 25,226 | 9,336 |
| Financing Cash Flow | $66,230 | $5,451 | $110,025 | $16,143 | $1,336 |
| Beginning Cash Position | 13,146 | 2,336 | 16,952 | 9,210 | 22,962 |
| End Cash Position | 26,028 | 13,146 | 2,336 | 16,952 | 9,210 |
| Net Cash Flow | $12,882 | $10,810 | $-14,616 | $7,742 | $-13,752 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,221 | -41,886 | -33,075 | -15,301 | -20,013 |
| Capital Expenditure | -4,215 | -1,641 | -192 | -202 | -79 |
| Free Cash Flow | -37,436 | -43,527 | -33,267 | -15,503 | -20,092 |